Some studies, including whole exome sequencing analysis, found that HER2 is constitutively active due to somatic mutation, amplification and the presence of HPV integration sites close to the ERBB2 gene in cervical cancer [316]. The gene discussed is ERBB2; the disease is cervical carcinoma.